首页> 外文OA文献 >Minimal T-Cell-Stimulatory Sequences and Spectrum of HLA Restriction of Immunodominant CD4+ T-Cell Epitopes within Hepatitis C Virus NS3 and NS4 Proteins†
【2h】

Minimal T-Cell-Stimulatory Sequences and Spectrum of HLA Restriction of Immunodominant CD4+ T-Cell Epitopes within Hepatitis C Virus NS3 and NS4 Proteins†

机译:丙型肝炎病毒NS3和NS4蛋白中最小的T细胞刺激序列和HLA限制免疫抗原CD4 + T细胞表位的谱†

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

The hepatitis C virus (HCV)-specific CD4+ T-cell response against nonstructural proteins is strongly associated with successful viral clearance during acute hepatitis C. To further develop these observations into peptide-based vaccines and clinical immunomonitoring tools like HLA class II tetramers, a detailed characterization of immunodominant CD4+ T-cell epitopes is required. We studied peripheral blood mononuclear cells from 20 patients with acute hepatitis C using 83 overlapping 20-mer peptides covering the NS3 helicase and NS4. Eight peptides were recognized by ≥40% of patients, and specific CD4+ T-cell clones were obtained for seven of these and three additional, subdominant epitopes. Mapping of minimal stimulatory sequences defined epitopes of 8 to 13 amino acids in length, but optimal T-cell stimulation was observed with 10- to 15-mers. While some epitopes were presented by different HLA molecules, others were presented by only a single HLA class II molecule, which has implications for patient selection in clinical trials of peptide-based immunotherapies. In conclusion, using two different approaches we identified and characterized a set of CD4+ T-cell epitopes in the HCV NS3-NS4 region which are immunodominant in patients achieving transient or persistent viral control. This information allows the construction of a valuable panel of HCV-specific HLA class II tetramers for further study of CD4+ T-cell responses in chronic hepatitis C. The finding of immunodominant epitopes with very constrained HLA restriction has implications for patient selection in clinical trials of peptide-based immunotherapies.
机译:针对非结构蛋白的丙型肝炎病毒(HCV)特异性CD4 + T细胞反应与急性丙型肝炎期间成功清除病毒密切相关。为了将这些发现进一步发展为基于肽的疫苗和临床免疫监测工具,例如HLA II类四聚体,需要对免疫显性CD4 + T细胞表位进行详细表征。我们使用覆盖NS3解旋酶和NS4的83个重叠的20-mer肽研究了20例急性丙型肝炎患者的外周血单个核细胞。 ≥40%的患者可识别八种肽,并针对其中的七个和另外三个主要表位获得了特异性的CD4 + T细胞克隆。最小刺激序列的图谱定义了长度为8到13个氨基酸的表位,但是在10到15聚体下观察到了最佳的T细胞刺激。尽管某些表位由不同的HLA分子呈递,而其他表位仅由单个HLA II类分子呈递,这对基于肽的免疫疗法的临床试验中的患者选择具有影响。总之,我们使用两种不同的方法在HCV NS3-NS4区域中鉴定并表征了一组CD4 + T细胞表位,这些表位在实现短暂或持续病毒控制的患者中具有免疫优势。该信息可用于构建有价值的HCV特异性HLA II类四聚体面板,以进一步研究慢性丙型肝炎中CD4 + T细胞应答。HLA限制非常严格的免疫显性表位的发现对患者的临床选择具有重要意义。基于肽的免疫疗法。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号